{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:29:21Z","timestamp":1790256561344,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T00:00:00Z","timestamp":1473897600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81301093"],"award-info":[{"award-number":["81301093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12883-016-0689-x","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T23:50:05Z","timestamp":1473897005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"16","author":[{"given":"Xueping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwei","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Fang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"issue":"1","key":"689_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1559-0275-10-19","volume":"10","author":"AM Varghese","year":"2013","unstructured":"Varghese AM, Sharma A, Mishra P, Vijayalakshmi K, Harsha HC, Sathyaprabha TN, Bharath SM, Nalini A, Alladi PA, Raju TR. Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis. Clin Proteomics. 2013;10(1):19.","journal-title":"Clin Proteomics"},{"issue":"1\u20132","key":"689_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jns.2014.12.016","volume":"348","author":"V Pagliardini","year":"2015","unstructured":"Pagliardini V, Pagliardini S, Corrado L, Lucenti A, Panigati L, Bersano E, Servo S, Cantello R, D'Alfonso S, Mazzini L. Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. J Neurol Sci. 2015;348(1\u20132):245\u201350.","journal-title":"J Neurol Sci"},{"issue":"6","key":"689_CR3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","volume":"66","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider J, Petzold A, Sussmuth SD, Ludolph AC, Tumani H. Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology. 2006;66(6):852\u20136.","journal-title":"Neurology"},{"issue":"4","key":"689_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00415-009-0131-z","volume":"256","author":"TS Reijn","year":"2009","unstructured":"Reijn TS, Abdo WF, Schelhaas HJ, Verbeek MM. CSF neurofilament protein analysis in the differential diagnosis of ALS. J Neurol. 2009;256(4):615\u20139.","journal-title":"J Neurol"},{"issue":"2","key":"689_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/21678421.2012.729596","volume":"14","author":"J Ganesalingam","year":"2013","unstructured":"Ganesalingam J, An J, Bowser R, Andersen PM, Shaw CE. pNfH is a promising biomarker for ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(2):146\u20139.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"689_CR6","first-page":"12","volume":"87","author":"P Steinacker","year":"2016","unstructured":"Steinacker P, Feneberg E, Weishaupt J, Brettschneider J, Tumani H, Andersen PM, von Arnim CA, Bohm S, Kassubek J, Kubisch C, et al. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J Neurol Neurosurg Psychiatry. 2016;87(1):12\u201320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"689_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0166-2236(03)00199-1","volume":"26","author":"TB Shea","year":"2003","unstructured":"Shea TB, Jung C, Pant HC. Does neurofilament phosphorylation regulate axonal transport? Trends Neurosci. 2003;26(8):397\u2013400.","journal-title":"Trends Neurosci"},{"issue":"11","key":"689_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nrneurol.2011.151","volume":"7","author":"R Bowser","year":"2011","unstructured":"Bowser R, Turner MR, Shefner J. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nat Rev Neurol. 2011;7(11):631\u20138.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"689_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","volume":"117","author":"J Ganesalingam","year":"2011","unstructured":"Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem. 2011;117(3):528\u201337.","journal-title":"J Neurochem"},{"issue":"1","key":"689_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/17482968.2011.627589","volume":"13","author":"M Otto","year":"2012","unstructured":"Otto M, Bowser R, Turner M, Berry J, Brettschneider J, Connor J, Costa J, Cudkowicz M, Glass J, Jahn O, et al. Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotroph Lateral Scler. 2012;13(1):1\u201310.","journal-title":"Amyotroph Lateral Scler"},{"issue":"4","key":"689_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jnnp-2012-303768","volume":"84","author":"KB Boylan","year":"2013","unstructured":"Boylan KB, Glass JD, Crook JE, Yang C, Thomas CS, Desaro P, Johnston A, Overstreet K, Kelly C, Polak M, et al. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84(4):467\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"689_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","volume":"66","author":"F Kimura","year":"2006","unstructured":"Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, Shinoda K, Sugino M, Hanafusa T. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66(2):265\u20137.","journal-title":"Neurology"},{"issue":"3","key":"689_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/17482960801942695","volume":"9","author":"E Beghi","year":"2008","unstructured":"Beghi E, Millul A, Logroscino G, Vitelli E, Micheli A. Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9(3):163\u20137.","journal-title":"Amyotroph Lateral Scler"},{"issue":"3","key":"689_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000089935","volume":"54","author":"S Sotgiu","year":"2005","unstructured":"Sotgiu S, Barone R, Zanda B, Arru G, Fois ML, Arru A, Rosati G, Marchetti B, Musumeci S. Chitotriosidase in patients with acute ischemic stroke. Eur Neurol. 2005;54(3):149\u201353.","journal-title":"Eur Neurol"},{"issue":"2","key":"689_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12013-012-9471-x","volume":"66","author":"M Rosa Di","year":"2013","unstructured":"Di Rosa M, Malaguarnera G, De Gregorio C, D'Amico F, Mazzarino MC, Malaguarnera L. Modulation of chitotriosidase during macrophage differentiation. Cell Biochem Biophys. 2013;66(2):239\u201347.","journal-title":"Cell Biochem Biophys"},{"issue":"5\u20136","key":"689_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/10408360490504934","volume":"41","author":"M Mussap","year":"2004","unstructured":"Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci. 2004;41(5\u20136):467\u2013550.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1\u20132","key":"689_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.brainres.2005.10.063","volume":"1066","author":"A Nagai","year":"2005","unstructured":"Nagai A, Ryu JK, Terashima M, Tanigawa Y, Wakabayashi K, McLarnon JG, Kobayashi S, Masuda J, Kim SU. Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B. Brain Res. 2005;1066(1\u20132):120\u20138.","journal-title":"Brain Res"},{"issue":"8","key":"689_CR18","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1212\/01.wnl.0000203129.82104.07","volume":"66","author":"GM Pasinetti","year":"2006","unstructured":"Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, et al. Identification of potential CSF biomarkers in ALS. Neurology. 2006;66(8):1218\u201322.","journal-title":"Neurology"},{"issue":"5","key":"689_CR19","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1471-4159.2005.03478.x","volume":"95","author":"S Ranganathan","year":"2005","unstructured":"Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, Newhall K, Cudkowicz ME, Brown Jr RH, Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem. 2005;95(5):1461\u201371.","journal-title":"J Neurochem"},{"issue":"5\u20136","key":"689_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/21678421.2014.884592","volume":"15","author":"S Lehnert","year":"2014","unstructured":"Lehnert S, Costa J, de Carvalho M, Kirby J, Kuzma-Kozakiewicz M, Morelli C, Robberecht W, Shaw P, Silani V, Steinacker P, et al. Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5\u20136):344\u201350.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"12","key":"689_CR21","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1002\/pmic.200402039","volume":"5","author":"O Carrette","year":"2005","unstructured":"Carrette O, Burkhard PR, Hughes S, Hochstrasser DF, Sanchez JC. Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process? Proteomics. 2005;5(12):3060\u20135.","journal-title":"Proteomics"},{"issue":"12","key":"689_CR22","doi-asserted-by":"publisher","first-page":"e15133","DOI":"10.1371\/journal.pone.0015133","volume":"5","author":"ME Wilson","year":"2010","unstructured":"Wilson ME, Boumaza I, Lacomis D, Bowser R. Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. PLoS One. 2010;5(12):e15133.","journal-title":"PLoS One"},{"issue":"12","key":"689_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1212\/WNL.0b013e3181d5dc3b","volume":"74","author":"SD Sussmuth","year":"2010","unstructured":"Sussmuth SD, Sperfeld AD, Hinz A, Brettschneider J, Endruhn S, Ludolph AC, Tumani H. CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Neurology. 2010;74(12):982\u20137.","journal-title":"Neurology"},{"issue":"5778","key":"689_CR24","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1126\/science.1123511","volume":"312","author":"S Boillee","year":"2006","unstructured":"Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312(5778):1389\u201392.","journal-title":"Science"},{"issue":"3","key":"689_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nn2047","volume":"11","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11(3):251\u20133.","journal-title":"Nat Neurosci"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0689-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-016-0689-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0689-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T15:34:48Z","timestamp":1487691288000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-016-0689-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1186\/s12883-016-0689-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]},"article-number":"173"}}